| 000 | 01749 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516141728.0 | ||
| 264 | 0 | _c20130912 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/CAD.0b013e32836009d7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMezencev, Roman | |
| 245 | 0 | 0 |
_aMolecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cJun 2013 |
||
| 300 |
_a504-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCellular Senescence _xdrug effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aGenes, myc |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitomycin _xpharmacology |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aWang, Lijuan | |
| 700 | 1 | _aXu, Wenwei | |
| 700 | 1 | _aKim, Byungkyu | |
| 700 | 1 | _aSulchek, Todd A | |
| 700 | 1 | _aDaneker, George W | |
| 700 | 1 | _aMcDonald, John F | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 24 _gno. 5 _gp. 504-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0b013e32836009d7 _zAvailable from publisher's website |
| 999 |
_c22598032 _d22598032 |
||